Prostate Cancer Diagnosis, Treatment in Older Men Incurs Needless Medicare Costs, Study Shows

Prostate Cancer Diagnosis, Treatment in Older Men Incurs Needless Medicare Costs, Study Shows
Prostate cancer patients age 70 or older are unlikely to die of the disease, but Medicare is spending nearly $400 million annually on detection and treatment in these men, a study shows. Approximately $150 million is attributed to men with low-grade prostate cancer, which could be treated with active surveillance instead of more aggressive methods. Researchers

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. Bill Peters says:

    Let’s face it, diagnosis and treatment of any disease, much less cancer, in people 70 and older will cost more to Medicare than not treating the disease. We do not need a research study to demonstrate that outcome.

    The problem is the wrong dependent variable was selected for evaluation of a treatment, which should be a ratio years of quality of life of the individual with the diagnosis per dollar spent.

    By the way, I am a doctoral level social scientist, about to turn 73, with metastatic prostate cancer one year after prostate removal.

Leave a Comment

Your email address will not be published. Required fields are marked *